Literature DB >> 19412837

Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood.

Jelmer R Prins1, Hendrik M Boelens, Janneke Heimweg, Sicco Van der Heide, Anthony E Dubois, Antoon J Van Oosterhout, Jan Jaap H M Erwich.   

Abstract

OBJECTIVE: Immunological mechanisms are involved in the pathophysiology of preeclampsia. During pregnancy there is an increase in regulatory T (Treg) cells, which has an important role in regulating tolerance to the immunologically distinct fetus. We hypothesised that percentages of Treg cells are decreased in preeclamptic patients.
METHODS: Peripheral blood was obtained from 26 healthy pregnant controls and 18 preeclamptic patients. Treg cells were measured using flow-cytometry.
RESULTS: Women with pregnancies complicated by preeclampsia had significantly lower percentages of CD4(+)FOXP3(+) Treg cells.
CONCLUSION: We conclude that a deficiency of regulatory T cells may play a role in the pathophysiology of preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19412837     DOI: 10.1080/10641950802601237

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  59 in total

1.  17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model.

Authors:  Lorena M Amaral; Denise C Cornelius; Ashlyn Harmon; Janae Moseley; James N Martin; Babbette LaMarca
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Pregnancy-associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs.

Authors:  A Steinborn; E Schmitt; A Kisielewicz; S Rechenberg; N Seissler; K Mahnke; M Schaier; M Zeier; C Sohn
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

3.  Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia.

Authors:  B Lamarca
Journal:  Minerva Ginecol       Date:  2012-08

Review 4.  Elucidating immune mechanisms causing hypertension during pregnancy.

Authors:  Babbette LaMarca; Denise Cornelius; Kedra Wallace
Journal:  Physiology (Bethesda)       Date:  2013-07

5.  Interleukin-4 supplementation improves the pathophysiology of hypertension in response to placental ischemia in RUPP rats.

Authors:  Jesse N Cottrell; Lorena M Amaral; Ashlyn Harmon; Denise C Cornelius; Mark W Cunningham; Venkata Ramana Vaka; Tarek Ibrahim; Florian Herse; Gerd Wallukat; Ralf Dechend; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-01-09       Impact factor: 3.619

Review 6.  T cell behavior at the maternal-fetal interface.

Authors:  Patrice Nancy; Adrian Erlebacher
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

Review 7.  Uterine Regulatory T cells, IL-10 and hypertension.

Authors:  Tania Nevers; Satyan Kalkunte; Surendra Sharma
Journal:  Am J Reprod Immunol       Date:  2011-07       Impact factor: 3.886

8.  Association between cytokine profile and transcription factors produced by T-cell subsets in early- and late-onset pre-eclampsia.

Authors:  Vanessa R Ribeiro; Mariana Romao-Veiga; Graziela G Romagnoli; Mariana L Matias; Priscila R Nunes; Vera Therezinha M Borges; Jose C Peracoli; Maria Terezinha S Peracoli
Journal:  Immunology       Date:  2017-06-19       Impact factor: 7.397

9.  Regulatory T cells in preeclampsia: some answers, more questions?

Authors:  Ana S Cerdeira; Hernan D Kopcow; S Ananth Karumanchi
Journal:  Am J Pathol       Date:  2012-10-11       Impact factor: 4.307

10.  An increased population of regulatory T cells improves the pathophysiology of placental ischemia in a rat model of preeclampsia.

Authors:  Denise C Cornelius; Lorena M Amaral; Ashlyn Harmon; Kedra Wallace; Alexia J Thomas; Nathan Campbell; Jeremy Scott; Florian Herse; Nadine Haase; Janae Moseley; Gerd Wallukat; Ralf Dechend; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-19       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.